Recently, Snibe receives the CE mark for its Rapisafe^TM SARS-CoV-2 Ag test (Colloidal Gold), which further confirmed that the quality of our Self-Testing kits is in line with international standards.

From August 29th to 31st, 2019, the 15th National Congress of Laboratory Medicine (NCLM 2019), hosted by Chinese Medical Association and Chinese Society of Laboratory Medicine, was held at Suzhou International Expo Centre.

Recently, Snibe has passed the IFCC External Quality Assessment Scheme for Reference Laboratories in Laboratory Medicine (IFCC-RELA), and 9 assays from Snibe reference laboratory achieved excellent results during the assessment, including 25-OH-Vitamin D3, 17-OH Progesterone, AP, ALT, Amylase, AST, CK, GGT and LDH.

Aiming to further explore the clinical application of serological indicators in early screening and diagnosis of HCC, the School of Basic Medical Sciences Peking University (SBMS, PKU) held an online meeting on June 25, 2022, to officially announce the launch of the project: Multicenter Study in Evaluating the Combination of Multiple Indicators in HCC Screening. Snibe is the exclusive industry supporter.

Snibe received the CE certificate (List A) for MAGLUMI? HBsAg (CLIA) assay On March 11, 2022. It further proves the high reliability of the quality and performance of Snibe products, as well as a verification of Snibe’s leading position in the field of chemiluminescence.